Provided by Tiger Trade Technology Pte. Ltd.

Baxter

26.00
-0.1300-0.50%
Post-market: 26.020.0200+0.08%19:49 EDT
Volume:3.99M
Turnover:104.06M
Market Cap:13.44B
PE:-12.60
High:26.35
Open:25.91
Low:25.86
Close:26.13
52wk High:30.00
52wk Low:15.73
Shares:517.00M
Float Shares:514.53M
Volume Ratio:0.91
T/O Rate:0.78%
Dividend:0.20
Dividend Rate:0.77%
EPS(TTM):-2.0641
EPS(LYR):-1.8655
ROE:-14.37%
ROA:2.85%
PB:2.17
PE(LYR):-13.94

Loading ...

U.S. Research ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics

Reuters
·
Jul 27

Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX) and Baxter International (BAX)

TIPRANKS
·
Jul 27

Baxter International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 25

Earning Preview: Baxter revenue is expected to decrease by 1.06%, and institutional views are mixed-to-cautious

Earnings Agent
·
Jul 24

KTEK Aerosystems Director Baxter Increases Shareholding via On-Market Purchase

TIPRANKS
·
Jul 23

How Investors May Respond To Baxter (BAX) Class I VOLARA Recall And Quality Control Scrutiny

Simply Wall St.
·
Jul 23

Baxter International Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 23

Baxter International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

Baxter International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Baxter International Inc. Stock Climbs 5.4%, Outperforms Peers

Dow Jones
·
Jul 17

Movement Alert|Baxter International Rises 5.03% in Regular Trading, Healthcare Equipment Sector Rallies Broadly

Market Focus
·
Jul 17

Baxter International is Maintained at Neutral by Goldman Sachs

Dow Jones
·
Jul 15

Baxter International Updates Segment Reporting Structure and Metrics

TIPRANKS
·
Jul 15

Baxter International Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

Baxter - Shared Corporate Expenses to Remain Unallocated in Segment Reporting - SEC Filing

THOMSON REUTERS
·
Jul 15

Baxter - Pharmaceuticals Segment NOW Reported Within Infusion Therapies & Platforms Division - SEC Filing

THOMSON REUTERS
·
Jul 15

Baxter - Changes Reportable Segments to Two Segments Effective Q2 2026 - SEC Filing

THOMSON REUTERS
·
Jul 15

Baxter: Changes Do not Impact Co's Previously Issued Consolidated Financial Statements Except for Its Segment Disclosures

THOMSON REUTERS
·
Jul 15

Movement Alert|Baxter International Falls 5.14% in Regular Trading, Goldman Sachs Raises Target but Maintains Neutral as Sector Sells Off

Market Focus
·
Jul 14

Goldman Sachs Adjusts Price Target on Baxter International to $21 From $19, Maintains Neutral Rating

MT Newswires Live
·
Jul 14